SCHEMBL3277683

SCHEMBL3277683

CCCCCCCCCC(=O)C(=O)c1ccc(O)c(OC)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.62
CYP3A4 P08684 2/20 0.62
CYP2C9 P11712 2/20 0.62
CYP2C19 P33261 2/20 0.62
CYP2C8 P10632 1/20 0.62
CYP2B6 P20813 1/20 0.62
MEN1 O00255 1/20 0.62
RAB9A P51151 1/20 0.62
KMT2A Q03164 1/20 0.62
ALDH1A1 P00352 1/20 0.56
CYP2D6 P10635 1/20 0.56
HPGD P15428 1/20 0.56
ALOX15 P16050 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
KDM4E B2RXH2 1/20 0.55
POLB P06746 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29522540 1.00 CYP1A2 (0.62) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL3276650 0.93 HTR1A (0.61) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL28324785 0.86 CYP1A2 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL28898000 0.86 HTR1A (0.60) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL20476155 0.86 CYP1A2 (0.61) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL28541651 0.86 CYP1A2 (0.61) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22390229 0.84 CYP1A2 (0.59) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
Vanillic Acid SCHEMBL31550996 0.82 HTT (0.78) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
Dodecanoate SCHEMBL109696 0.82 HTT (0.68) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL3278089 0.82 MEN1 (0.74) CYP1A2MEN1RAB9AKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087524-A1 Flavour Improving Substances GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2010-04-08 US claimed
EP-2124630-A1 FLAVOUR IMPROVING SUBSTANCES Givaudan Nederland Services B.V. (NL) 2009-12-02 EP claimed
WO-2008105652-A1 FLAVOUR IMPROVING SUBSTANCES GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-09-04 WO claimed
EP-4680039-A1 COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF DSM-Firmenich AG (CH) 2026-01-21 EP disclosed
WO-2024251755-A1 COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF DSM-FIRMENICH AG (CH) 2024-12-12 WO disclosed
US-20230148641-A1 FLAVOR COMPOSITION FIRMENICH SA (CH) 2023-05-18 US disclosed
EP-4125427-A1 FLAVOR COMPOSITION Firmenich SA (CH) 2023-02-08 EP disclosed
CN-115279206-A Flavor composition 弗门尼舍有限公司 2022-11-01 CN disclosed
WO-2021198199-A1 FLAVOR COMPOSITION FIRMENICH SA (CH) 2021-10-07 WO disclosed
CN-108135859-B Packaging method 罗地亚经营管理公司 2021-08-10 CN disclosed
US-11071318-B2 Encapsulation process RHODIA OPERATIONS (FR) 2021-07-27 US disclosed
US-20180235268-A1 ENCAPSULATION PROCESS SPECIALTY OPERATIONS FRANCE (FR) 2018-08-23 US disclosed
EP-3334420-A1 ENCAPSULATION PROCESS Rhodia Operations (FR) 2018-06-20 EP disclosed
US-20100087524-A1 Flavour Improving Substances GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2010-04-08 US disclosed
US-20100087524-A1 Flavour Improving Substances GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2010-04-08 US disclosed
EP-2124630-A1 FLAVOUR IMPROVING SUBSTANCES Givaudan Nederland Services B.V. (NL) 2009-12-02 EP disclosed
EP-2124630-A1 FLAVOUR IMPROVING SUBSTANCES Givaudan Nederland Services B.V. (NL) 2009-12-02 EP disclosed
WO-2008105652-A1 FLAVOUR IMPROVING SUBSTANCES GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-09-04 WO disclosed
WO-2008105652-A1 FLAVOUR IMPROVING SUBSTANCES GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087524-A1 Flavour Improving Substances SDHA, DLAT, LPO CYP1A2 1436/4885CYP3A4 1400/4885CYP2C9 1181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.